- If you are wondering whether Option Care Health's current share price still reflects its true worth, you are not alone; many investors are asking the same question.
- The stock last closed at US$27.74, after a 3.0% move over 7 days, a 7.0% decline over 30 days and a year to date return of 14% decline, with a 1 year return of 15.4% decline and a 3 year return of 12.7% decline, while the 5 year return sits at 47.0%.
- Recent news flow around Option Care Health has mainly centered on its role in US healthcare services and how investors are weighing that against wider sector sentiment. This backdrop helps explain why the share price has seen mixed shorter term returns, even though the longer term track record over 5 years is more positive.
- Against this context, the company currently holds a valuation score of 4 out of 6. This sets the scene to compare different valuation approaches next, with an even more helpful way of thinking about value waiting at the end of the article.
Approach 1: Option Care Health Discounted Cash Flow (DCF) Analysis
A Discounted Cash Flow, or DCF, model takes estimates of the cash a business could generate in the future and discounts those amounts back to today to arrive at an estimated intrinsic value per share.
For Option Care Health, the model used is a 2 Stage Free Cash Flow to Equity approach based on cash flow projections. The latest twelve month Free Cash Flow stands at about US$213.6 million. Analyst projections provided for 2026 and 2027 show Free Cash Flow of US$301.5 million and US$332.5 million respectively, with later years extrapolated by Simply Wall St and currently set to zero in this dataset from 2028 onward.
Combining these cash flows, the model estimates an intrinsic value of about US$3.66 per share, compared with the recent share price of US$27.74. This implies the shares trade at a very large premium to the DCF estimate, with the discount figure indicating the stock is more than seven times the modelled fair value.
Result: OVERVALUED
Our Discounted Cash Flow (DCF) analysis suggests Option Care Health may be overvalued by 658.2%. Discover 61 high quality undervalued stocks or create your own screener to find better value opportunities.
Approach 2: Option Care Health Price vs Earnings
For a profitable company, the P/E ratio is a straightforward way to think about what you are paying for each dollar of current earnings. This is why it is often the first metric investors check. A higher or lower P/E can be influenced by what the market expects for future earnings growth and how risky those earnings are perceived to be, so there is no single “right” number in isolation.
Option Care Health currently trades on a P/E of 20.9x. That sits just below the broader Healthcare industry average of 22.5x and well below the peer group average of 55.0x. This indicates that investors are paying less for its earnings than for many comparable stocks in the same space.
Simply Wall St’s Fair Ratio for Option Care Health is 23.4x. This is a proprietary estimate of what the P/E might be given factors such as the company’s earnings growth profile, industry, profit margins, market cap and assessed risks. Because it blends these company specific factors, the Fair Ratio aims to be more tailored than a simple comparison with peers or the industry average.
Comparing the current P/E of 20.9x with the Fair Ratio of 23.4x indicates that the shares are trading below that Fair Ratio estimate.
Result: UNDERVALUED
P/E ratios tell one story, but what if the real opportunity lies elsewhere? Start investing in legacies, not executives. Discover our 18 top founder-led companies.
Upgrade Your Decision Making: Choose your Option Care Health Narrative
Earlier it was mentioned that there is an even better way to understand valuation, and that is Narratives. These let you set out a clear story for Option Care Health on Simply Wall St’s Community page by linking your view of its business drivers to specific revenue, earnings and margin estimates. Those estimates are then turned into a fair value that you can compare with the current share price to frame buy or sell decisions. The numbers update when new news or earnings arrive. One investor might build a Narrative close to the more bullish analyst view that sees home and alternate site infusion growth, payer partnerships, margin projects and buybacks supporting a Fair Value in line with a US$45.00 target. Another investor might focus on reimbursement pressure, therapy mix risk and competition to anchor on a Fair Value nearer US$37.00. Both can then see in real time how fresh information shifts their story and valuation.
Do you think there's more to the story for Option Care Health? Head over to our Community to see what others are saying!
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com